Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
O Martínez-Iglesias, L Ruiz-Llorente… - Clinical and …, 2008 - Springer
Histone deacetylases (HDACs) remove the acetyl groups of lysine residues of histone tails
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
O Martínez-Iglesias, L Ruiz-Llorente… - … publication of the …, 2008 - pubmed.ncbi.nlm.nih.gov
Histone deacetylases (HDACs) remove the acetyl groups of lysine residues of histone tails
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
O Martínez-Iglesias, L Ruiz-Llorente… - Clinical and …, 2008 - infona.pl
Histone deacetylases (HDACs) remove the acetyl groups of lysine residues of histone tails
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer.
O Martínez-Iglesias, L Ruiz-Llorente… - Clinical & …, 2008 - search.ebscohost.com
Histone deacetylases (HDACs) remove the acetyl groups of lysine residues of histone tails
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
O Martínez-Iglesias, L Ruiz-Llorente… - 2008 - digital.csic.es
Histone deacetylases (HDACs) remove the acetyl groups of lysine residues of histone tails
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer.
O Martínez-Iglesias, L Ruiz-Llorente… - … : Official Publication of …, 2008 - europepmc.org
Histone deacetylases (HDACs) remove the acetyl groups of lysine residues of histone tails
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
O Martínez-Iglesias, L Ruiz-Llorente… - Clin. transl. oncol …, 2008 - pesquisa.bvsalud.org
Histone deacetylases (HDACs) remove the acetyl groups of lysine residues of histone tails
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
[PDF][PDF] Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
O Martínez-Iglesias, L Ruiz-Llorente… - Clin Transl …, 2008 - researchgate.net
Histone deacetylases (HDACs) remove the acetyl groups of lysine residues of histone tails
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …
leading to chromatin compaction and transcriptional repression. In addition, HDACs can …